Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

NCT00287716 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

435

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: Pirfenidone
DRUG: Placebo

Sponsor

Genentech, Inc.